| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |